HCM
ALXN
Harvey Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,200
| Closed | -$220K | – | 89 |
|
|
2021
Q2 | $220K | Buy |
+1,200
| New | +$220K | 0.07% | 77 |
|
|
2021
Q1 | – | Sell |
-47,806
| Closed | -$7.47M | – | 83 |
|
|
2020
Q4 | $7.47M | Sell |
47,806
-6,305
| -12% | -$985K | 3.03% | 9 |
|
|
2020
Q3 | $6.19M | Buy |
54,111
+4,570
| +9% | +$523K | 2.76% | 9 |
|
|
2020
Q2 | $5.56M | Sell |
49,541
-8,100
| -14% | -$909K | 2.75% | 10 |
|
|
2020
Q1 | $5.18M | Sell |
57,641
-3,875
| -6% | -$348K | 3.49% | 11 |
|
|
2019
Q4 | $6.65M | Buy |
61,516
+27,806
| +82% | +$3.01M | 2.95% | 9 |
|
|
2019
Q3 | $3.3M | Buy |
+33,710
| New | +$3.3M | 1.64% | 24 |
|